Perfil
Jason Slingsby was the founder of ProtAffin Biotechnologie AG, founded in 2005, where the title held was Chief Executive Officer.
Dr. Slingsby is currently Chief Executive Officer at Tozaro Ltd., starting in 2025.
Former jobs include Chief Business Officer at Oxford Biomedica Plc from 2018 to 2023, Principal at InterCel, Inc., Principal at Sosei Co. Ltd., and Member-Supervisory Board at Zytoprotec GmbH.
Education includes a doctorate from Imperial College London and an MBA from London Business School.
Cargos activos de Jason Slingsby
| Empresas | Cargo | Inicio |
|---|---|---|
MIP Discovery Ltd. (United Kingdom)
MIP Discovery Ltd. (United Kingdom) BiotechnologyHealth Technology Develops and manufactures viral vectors in cell & gene therapy | Director Ejecutivo | 09/06/2025 |
Antiguos cargos conocidos de Jason Slingsby.
| Empresas | Cargo | Fin |
|---|---|---|
| OXFORD BIOMEDICA PLC | Corporate Officer/Principal | 01/05/2023 |
Zytoprotec GmbH
Zytoprotec GmbH Medical/Nursing ServicesHealth Services Provides dialysis renal replacement therapy services | Director/Miembro de la Junta | - |
Sosei Co. Ltd.
Sosei Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Researches and develops bio pharmaceutical drugs and provides services in clinical test preparation | Corporate Officer/Principal | - |
InterCel, Inc.
InterCel, Inc. Wireless TelecommunicationsCommunications Operates cellular telephone system | Corporate Officer/Principal | - |
ProtAffin Biotechnologie AG
ProtAffin Biotechnologie AG Pharmaceuticals: MajorHealth Technology Develops anti-inflammatory products | Director Ejecutivo | - |
Formación de Jason Slingsby.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 8 |
|---|---|
Oxford Biomedica Plc
Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
Imperial College London
Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
InterCel, Inc.
InterCel, Inc. Wireless TelecommunicationsCommunications Operates cellular telephone system | Communications |
Sosei Co. Ltd.
Sosei Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Researches and develops bio pharmaceutical drugs and provides services in clinical test preparation | Commercial Services |
London Business School
London Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ProtAffin Biotechnologie AG
ProtAffin Biotechnologie AG Pharmaceuticals: MajorHealth Technology Develops anti-inflammatory products | Health Technology |
Zytoprotec GmbH
Zytoprotec GmbH Medical/Nursing ServicesHealth Services Provides dialysis renal replacement therapy services | Health Services |
MIP Discovery Ltd. (United Kingdom)
MIP Discovery Ltd. (United Kingdom) BiotechnologyHealth Technology Develops and manufactures viral vectors in cell & gene therapy | Health Technology |
- Bolsa de valores
- Insiders
- Jason Slingsby
















